Rochester,NY 9/2/2009 12:05:47 AM
ACOR Acorda Therapeutics, Inc. last trade at 22.62 moving down for 1.59%
Acorda Therapeutics, Inc
ACOR Acorda Therapeutics, Inc. last trade at 22.62 moving down for 1.59%
Acorda Therapeutics, Inc.ACOR a biopharmaceutical company, engages in the identification, development, and commercialization of various therapies for the improvement of neurological functions,Last trade 22.62 moving down 0.36 cents volume 23,181 shares, During the day the stock ranged from 0.00 - 33.00 or 33 cents.
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Scroll to BOTTOM of this page for free stock alerts, or visit our site.
Last Trade: 22.62
Day's Range: N/A - N/A
52wk Range: 0.00 - 33.00
Change: Down 0.36 (1.59%)
Volume: 23,181
Avg Vol (3m): 498,643
ABOUT Acorda Therapeutics.
Acorda Therapeutics, Inc., a biopharmaceutical company, engages in the identification, development, and commercialization of various therapies for the improvement of neurological functions in people with multiple sclerosis (MS), spinal cord injury, and other disorders of the central nervous system in the United States. It markets Zanaflex Capsules and Zanaflex tablets, a short-acting drug indicated for the management of spasticity. The company?s lead product candidate is Fampridine-SR, which completed two positive Phase III clinical trials for the improvement of walking ability in patients with MS. Its preclinical programs comprise remyelination programs that include two distinct therapeutic approaches to stimulate repair of the damaged myelin sheath in MS, Glial Growth Factor 2, or GGF-2, and remyelinating antibodies; and Chondroitinase Program that develops second generation approaches to overcoming the proteoglycan matrix. Acorda Therapeutics sells its products through internal specialty sales force and contract pharmaceutical telesales organizations. The company was founded in 1995 and is based in Hawthorne, New York.
About Stock Einstein
StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://StockEinsteain.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinsteain, nor any of its affiliates are registered investment advisors or broker dealers.
